- Obstetrics and Gynecology
- Rehabilitation
- Reproductive Medicine
Abstract
STUDY QUESTION
What is the association between past infertility and the type and timing of menopause in midlife women?
SUMMARY ANSWER
Women with a history of infertility were more likely to experience surgical menopause overall and had elevated risk of earlier surgical menopause until age 43 years but experienced no differences in the timing of natural menopause.
WHAT IS KNOWN ALREADY
Infertility is experienced by 12–25% of women and is thought to reveal a propensity for poor health outcomes, such as chronic illness, later in life. However, little is known about whether infertility is linked with characteristics of the menopausal transition as women age, despite possible shared underlying pathways involving ovarian function and gynecologic disease.
STUDY DESIGN, SIZE, DURATION
Secondary analysis of a prospective cohort study of 13 243 midlife females recruited in Phase 1 of the Alberta’s Tomorrow Project (Alberta, Canada) and followed approximately every 4 years (2000–2022).
PARTICIPANTS/MATERIALS, SETTING, METHODS
Data were collected through standardized self-report questionnaires. History of infertility, defined as ever trying to become pregnant for more than 1 year without conceiving, was measured at baseline. Menopause characteristics were measured at each study follow-up. Menopause type was defined as premenopause, natural menopause, surgical menopause (bilateral oophorectomy), or indeterminate menopause (premenopausal hysterectomy with ovarian conservation). Timing of natural menopause was defined as the age at 1 full year after the final menstrual period, and timing of surgical and indeterminate menopause was defined as the age at the time of surgery. We used flexible parametric survival analysis for the outcome of menopause timing with age as the underlying time scale and multinomial logistic regression for the outcome of menopause type. Multivariable models controlled for race/ethnicity, education, parity, previous pregnancy loss, and smoking. Sensitivity analyses additionally accounted for birth history, menopausal hormone therapy, body mass index, chronic medical conditions, and age at baseline.
MAIN RESULTS AND THE ROLE OF CHANCE
Overall, 18.2% of women reported a history of infertility. Past infertility was associated with earlier timing of surgical menopause exclusively before age 43 years (age 35: adjusted hazard ratio 3.13, 95% CI 1.95–5.02; age 40: adjusted hazard ratio 1.83, 95% CI 1.40–2.40; age 45: adjusted hazard ratio 1.13, 95% CI 0.87–1.46) as well as greater odds of experiencing surgical menopause compared to natural menopause (adjusted odds ratio 1.40, 95% CI 1.18–1.66). Infertility was not associated with the timing of natural or indeterminate menopause.
LIMITATIONS, REASONS FOR CAUTION
Information on the underlying cause of infertility and related interventions was not collected, which precluded us from disentangling whether associations differed by infertility cause and treatment. Residual confounding is possible given that some covariates were measured at baseline and may not have temporally preceded infertility.
WIDER IMPLICATIONS OF THE FINDINGS
Women with a history of infertility were more likely to experience early surgical menopause and may therefore benefit from preemptive screening and treatment for gynecologic diseases to reduce bilateral oophorectomy, where clinically appropriate, and its associated health risks in midlife. Moreover, the lack of association between infertility and timing of natural menopause adds to the emerging knowledge that diminishing ovarian reserve does not appear to be a primary biological mechanism of infertility nor its downstream implications for women’s health.
STUDY FUNDING/COMPETING INTEREST(S)
Alberta’s Tomorrow Project is only possible due to the commitment of its research participants, its staff and its funders: Alberta Health, Alberta Cancer Foundation, Canadian Partnership Against Cancer and Health Canada, and substantial in-kind funding from Alberta Health Services. The views expressed herein represent the views of the author(s) and not of Alberta’s Tomorrow Project or any of its funders. This secondary analysis is funded by Project Grant Priority Funding in Women’s Health Research from the Canadian Institutes of Health Research (Grant no. 491439). N.V.S. is supported by a Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research. H.K.B. is supported by the Canada Research Chairs Program. E.A.B. is supported by an Early Career Investigator Award in Maternal, Reproductive, Child and Youth Health from the Canadian Institutes of Health Research. A.K.S. has received honoraria from Pfizer, Lupin, Bio-Syent, and Eisai and has received grant funding from Pfizer. N.V.S., H.K.B., and E.A.B. have no conflicts of interest to report.
TRIAL REGISTRATION NUMBER
N/A.
Need a simple solution for managing your BibTeX entries? Explore CiteDrive!
- Web-based, modern reference management
- Collaborate and share with fellow researchers
- Integration with Overleaf
- Comprehensive BibTeX/BibLaTeX support
- Save articles and websites directly from your browser
- Search for new articles from a database of tens of millions of references
Try out CiteDrive More from our Archive
-
DOI: 10.1002/uog.26309 2023
Effect of intrapartum epidural analgesia on rate of emergency delivery for presumed fetal compromise: nationwide registry‐based cohort study
S. E. Damhuis, H. Groen, B. Thilaganathan, W. Ganzevoort, S. J. Gordijn
-
DOI: 10.1002/uog.26308 2023
Epidural analgesia and emergency delivery for presumed fetal compromise: <i>post‐hoc</i> analysis of <scp>RAVEL</scp> multicenter randomized controlled trial
E. S. E. Tabernée Heijtmeijer, H. Groen, S. E. Damhuis, L. M. Freeman, J. M. Middeldorp, W. Ganzevoort, S. J. Gordijn
-
DOI: 10.1111/mcn.13546 2023
A qualitative study of public health nurses' perspectives and experiences on nutritional guidance for parents of infants and toddlers
Christine Helle, Elisabet R. Hillesund, Nina Cecilie Øverby
-
DOI: 10.1002/uog.26303 2023
Screening for pre‐eclampsia by maternal serum glycosylated fibronectin at 11−13 weeks' gestation
N. Sokratous, M. Bednorz, P. Sarli, O. E. Morillo Montes, A. Syngelaki, A. Wright, K. H. Nicolaides
-
DOI: 10.1097/ogx.0000000000001159 2023
Cannabis and Pregnancy: A Review
Sarena Hayer, Ava D. Mandelbaum, Lester Watch, Kimberly S. Ryan, Madeline A. Hedges, Jennifer A. Manuzak, Charles A. Easley, Danny J. Schust, Jamie O. Lo
-
DOI: 10.1002/ijgo.14989 2023
Descriptive spectrum of thiamine deficiency in pregnancy: A potentially preventable condition
Sobia Nisar, Ozaifa Kareem, Umar Muzaffer, Masood Tanvir, Mohd. Ashraf Ganaie, Rabia Nazir Ahmed
-
DOI: 10.1111/aogs.14602 2023
Association between levothyroxine treatment for maternal subclinical hypothyroidism with negative <scp>TPOAb</scp> and early child neurodevelopment: A prospective real‐world clinical trial
Zhekun Zhao, Qiongjie Zhou, Huanqiang Zhao, Yu Xiong, Xiaotian Li
-
DOI: 10.1111/jog.15743 2023
Development and internal validation of a multivariable prediction model for the quality of life of cervical cancer survivors
Jorge Cea García, Laura Ríos‐Pena, M. Carmen Rubio Rodríguez, Francisco Márquez Maraver, Inmaculada Rodríguez Jiménez
-
DOI: 10.1111/ajo.13719 2023
Intrahepatic cholestasis of pregnancy – Diagnosis and management: A consensus statement of the Society of Obstetric Medicine of Australia and New Zealand (<scp>SOMANZ</scp>): Executive summary
William M. Hague, Annette Briley, Leonie Callaway, Marloes Dekker Nitert, Jessica Gehlert, Dorothy Graham, Luke Grzeskowiak, Angela Makris, Corey Markus, Philippa Middleton, Michael J. Peek, Antonia Shand, Michael Stark, Jason Waugh
-
DOI: 10.1002/ijgo.14983 2023
Feasibility of 5‐fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (<scp>CIN</scp>) 2/3
Nerlyne Desravines, Chiu‐Hsieh Hsu, Sopan Mohnot, Vikrant Sahasrabuddhe, Margaret House, Edward Sauter, Siobhan O'Connor, Julie E. Bauman, H.‐H. Sherry Chow, Lisa Rahangdale